ZFP36L2 switch lets gut cells revert to stem state during healing and cancer spread
The RNA-binding protein ZFP36L2 couples stress sensing to dedifferentiation in gut repair and colorectal cancer metastasis, and its loss reshapes tumor cell fate.
Summary
Gut lining cells can revert to a stem-cell state after injury, and colorectal cancer cells hijack this ability to seed metastases. This study identifies the RNA-binding protein ZFP36L2, mutated in 5-10% of colorectal cancers, as a stress-responsive switch for that reversion. In mouse colon injury models, deleting Zfp36l2 blocked dedifferentiation into LGR5+ stem cells and impaired regeneration. In human colorectal cancer organoids, knocking down ZFP36L2 reduced metastatic seeding but pushed surviving cells toward non-canonical neuroendocrine and squamous-like fates. Patient metastases with ZFP36L2 mutations showed the same pattern: less LGR5 and more CHGB and CK5. The work frames ZFP36L2 as a link between stress and cell-fate plasticity. The last mechanistic section of the text was cut off, so the condensate findings are only partly covered here.
Detailed Summary
Why it matters: Cell plasticity is a hallmark of cancer, yet the molecular switches that let differentiated cells change identity are poorly understood. In the intestine, surviving differentiated cells can dedifferentiate into LGR5+ intestinal stem cells (ISCs) after injury. Colorectal cancer (CRC) cells exploit the same route to seed and regrow metastases. Metastases that instead adopt non-canonical squamous-like or neuroendocrine-like states are common and linked to worse outcomes.
What was studied: The authors found that ZFP36L2, an AU-rich-element-binding RNA-binding protein, is the gene most highly expressed in tumor ISC-like cells. It is co-expressed with AP-1 stress-response genes (FOS, FOSB, MYC, EGR1, ATF3, DUSP1) in single-cell data from normal colon and CRC. They tested function in mouse colon with epithelial-specific Zfp36l2 knockout (Vil1-cre), using dextran sodium sulfate (DSS) colitis and diphtheria-toxin ablation of LGR5+ cells (Lgr5-DTR). They also used organoids. In human CRC, they used four patient-derived organoid lines (two primary, two metastasis-derived) with inducible shRNA knockdown, plus CRISPR knockout. They ran orthotopic caecal, intrasplenic and spontaneous metastasis xenograft experiments in NSG mice and examined patient samples.
Key results: In mice, ZFP36L2 rose during injury and was re-expressed in the transit-amplifying and crypt-base compartments before Lgr5 returned. Knockout mice had normal baseline morphology but fewer LGR5+ cells. After DSS they showed greater weight loss, incomplete recovery, shortened colon and caecum, persistent inflammation and crypt loss. After LGR5+ ablation, they regenerated LGR5 poorly, and organoids from knockout cells re-formed fewer, smaller organoids. In CRC, knockdown reduced growth of canonical primary tumor organoids but not metastasis-derived ones. It strongly reduced liver and lung metastatic seeding, with sustained early signal loss in mice, though rare surviving cells later regrew. Knockdown organoids failed to re-express ISC markers (LGR5, ASCL2, AXIN2) during dedifferentiation and kept differentiation markers. Knockout organoids and metastases showed more KRT20 and neuroendocrine CHGB, and CRISPR knockouts showed squamous and osteoblast programs. In patient metastases, ZFP36L2 mutation was associated with lower LGR5 and higher CHGB and CK5, usually in separate cell clusters.
Implications: ZFP36L2 appears to couple AP-1-driven stress sensing to re-entry into the ISC state. Its loss is disadvantageous for lineage-restricted primary tumors but can select for plastic, non-canonical metastatic outgrowth. The abstract also reports that ZFP36L2 binds AU-rich stress-associated mRNAs and forms dynamic condensates tied to mRNA degradation and ending the stress response. The supplied text cuts off before those data.
Caveats: Much of the work uses mouse models, immunodeficient xenografts and organoids. The human mutation analysis rests on small sample numbers (8 wild-type and 4 mutant cases), and the mechanistic condensate data could not be assessed from the provided text.
Key Findings
- ZFP36L2 is highest in intestinal stem-like cells and co-expressed with AP-1 stress genes in normal colon and colorectal cancer.
- Epithelial Zfp36l2 deletion impaired dedifferentiation into LGR5+ stem cells and worsened regeneration after DSS colitis and LGR5+ cell ablation in mice.
- ZFP36L2 knockdown sharply reduced liver and lung metastatic seeding of human CRC organoids and blocked re-expression of stem-cell markers.
- Surviving ZFP36L2-deficient metastases shifted toward non-canonical neuroendocrine (CHGB) and squamous (CK5) states, mirroring ZFP36L2-mutant patient metastases.
- Per the abstract, ZFP36L2 binds AU-rich stress mRNAs and forms condensates linked to mRNA degradation and stress-response termination.
Methodology
The study combined single-cell RNA-seq analysis of paired normal, primary and metastatic human CRC with mouse intestinal injury models (DSS colitis, Lgr5-DTR ablation) using epithelial-specific Zfp36l2 knockout. Human CRC function was tested in four patient-derived organoids with inducible shRNA and CRISPR perturbation, orthotopic caecal and intrasplenic xenografts in NSG mice, and RNA FISH/immunostaining of patient tissue.
Study Limitations
Evidence comes mainly from mouse models, immunodeficient xenografts and organoids, with small patient sample sizes for mutant versus wild-type comparisons (4 vs 8). The provided text ends before the condensate and mRNA-binding experiments, so those mechanistic claims rest on the abstract. Causality in patients and any therapeutic targetability remain untested.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: